RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Recursion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:41 pm Sale | 2024-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | RA CAPITAL MANAGEMENT L.P. | 7,725,096 2.000% | -7,659,519 (-49.79%) | Filing |
| 2024-07-08 4:17 pm Purchase | 2024-06-28 | 13G | RECURSION PHARMACEUTICALS INC RXRX | RA CAPITAL MANAGEMENT L.P. | 15,384,615 5.900% | 15,384,615 (New Position) | Filing |